LABD vs. SPXU
Compare and contrast key facts about Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ProShares UltraPro Short S&P500 (SPXU).
LABD and SPXU are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABD is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (-300%). It was launched on May 28, 2015. SPXU is a passively managed fund by ProShares that tracks the performance of the S&P 500 Index (-300%). It was launched on Jun 25, 2009. Both LABD and SPXU are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LABD or SPXU.
Key characteristics
| LABD | SPXU | |
|---|---|---|
| YTD Return | -21.21% | -22.56% |
| 1Y Return | -42.85% | -49.43% |
| 3Y Return (Ann) | -31.34% | -30.58% |
| 5Y Return (Ann) | -55.56% | -46.28% |
| Sharpe Ratio | -0.46 | -1.48 |
| Daily Std Dev | 83.48% | 33.77% |
| Max Drawdown | -99.97% | -99.98% |
| Current Drawdown | -99.96% | -99.98% |
Correlation
The correlation between LABD and SPXU is 0.57, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LABD vs. SPXU - Performance Comparison
In the year-to-date period, LABD achieves a -21.21% return, which is significantly higher than SPXU's -22.56% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABD vs. SPXU - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than SPXU's 0.93% expense ratio.
Risk-Adjusted Performance
LABD vs. SPXU - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ProShares UltraPro Short S&P500 (SPXU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LABD vs. SPXU - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 5.84%, more than SPXU's 3.45% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 5.84% | 6.13% | 0.53% | 0.00% | 3.96% | 1.75% | 0.80% | 0.00% |
SPXU ProShares UltraPro Short S&P500 | 3.45% | 1.41% | 0.08% | 0.00% | 0.14% | 0.43% | 0.28% | 0.02% |
Drawdowns
LABD vs. SPXU - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.97%, roughly equal to the maximum SPXU drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for LABD and SPXU. For additional features, visit the drawdowns tool.
Volatility
LABD vs. SPXU - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 21.82% compared to ProShares UltraPro Short S&P500 (SPXU) at 9.98%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than SPXU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.